Oct 10
How We Will Cure Cancer: A VITALS Presentation by Karen Knudsen
Did you know that patients with household incomes of less than $50,000 annually are 30% less likely than those with higher incomes to participate in clinical trials? Even if you might have guessed that, would you have known that many of these patients are not ever offered the opportunity to participate?
Research and advocacy are how we will cure cancer. That was the message of Karen Knudsen, Ph.D., M.B.A., the CEO of the American Cancer Society and a National Cancer Institute-funded researcher, at an hour-long VITALS series at noon Thursday, Oct. 7.
Through her presentation and by answering questions from the audience, Dr. Knudsen identified barriers to health care – including lack of digital literacy and unconscious bias – as well as solutions and paths forward, such as making clinical trials more widely available to cancer patients.
NEOMED’s Visional Health Leadership in Action speaker series features a diverse range of experiences by innovative leaders in the medical sector. At each event, audience participants are invited to submit questions to the presenters – distinguished leaders in the fields of health care. Sessions are moderated by Monica Robins, senior health correspondent for WKYC-TV.
The next VITALS presentation will be by Art Papier, M.D., co-founder and CEO of VisualDx.
If you missed the Oct. 7 webinar, or if you’d like to listen again, here’s your chance.
